NX (9147) saw its Offering price today. It priced down nearly 9% from pre-announcement. No dilution, and net mitigants are half the offering. It priced -7% vs a Peer Basket. I'd buy on weakness
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.